306 related articles for article (PubMed ID: 15289798)
41. Valproic acid exhibits biphasic effects on apoptotic cell death of activated lymphocytes through differential modulation of multiple signaling pathways.
Chen Q; Ouyang DY; Geng M; Xu LH; Zhang YT; Wang FP; He XH
J Immunotoxicol; 2011; 8(3):210-8. PubMed ID: 21457087
[TBL] [Abstract][Full Text] [Related]
42. Modulation of adhesion and growth of colon and pancreatic cancer cells by the histone deacetylase inhibitor valproic acid.
Jones J; Bentas W; Blaheta RA; Makarevic J; Hudak L; Wedel S; Probst M; Jonas D; Juengel E
Int J Mol Med; 2008 Sep; 22(3):293-9. PubMed ID: 18698487
[TBL] [Abstract][Full Text] [Related]
43. Nuclear histone deacetylases are not required for global histone deacetylation during meiotic maturation in porcine oocytes.
Endo T; Kano K; Naito K
Biol Reprod; 2008 Jun; 78(6):1073-80. PubMed ID: 18305223
[TBL] [Abstract][Full Text] [Related]
44. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
Law AY; Lai KP; Lui WC; Wan HT; Wong CK
Exp Cell Res; 2008 Oct; 314(16):2975-84. PubMed ID: 18652825
[TBL] [Abstract][Full Text] [Related]
45. Neuroprotective effects of valproic acid following transient global ischemia in rats.
Xuan A; Long D; Li J; Ji W; Hong L; Zhang M; Zhang W
Life Sci; 2012 Mar; 90(11-12):463-8. PubMed ID: 22285595
[TBL] [Abstract][Full Text] [Related]
46. Histone deacetylase inhibitors differentially mediate apoptosis in prostate cancer cells.
Frønsdal K; Saatcioglu F
Prostate; 2005 Feb; 62(3):299-306. PubMed ID: 15389787
[TBL] [Abstract][Full Text] [Related]
47. Clinically relevant concentrations of valproic acid modulate melatonin MT(1) receptor, HDAC and MeCP2 mRNA expression in C6 glioma cells.
Kim B; Rincón Castro LM; Jawed S; Niles LP
Eur J Pharmacol; 2008 Jul; 589(1-3):45-8. PubMed ID: 18550052
[TBL] [Abstract][Full Text] [Related]
48. Peroxisome proliferator-activated receptor gamma agonists potentiate the cytotoxic effect of valproic acid in multiple myeloma cells.
Aouali N; Palissot V; El-Khoury V; Moussay E; Janji B; Pierson S; Brons NH; Kellner L; Bosseler M; Van Moer K; Berchem G
Br J Haematol; 2009 Dec; 147(5):662-71. PubMed ID: 19793255
[TBL] [Abstract][Full Text] [Related]
49. Disclosure of a pro-apoptotic glyceraldehyde-3-phosphate dehydrogenase promoter: anti-dementia drugs depress its activation in apoptosis.
Tsuchiya K; Tajima H; Yamada M; Takahashi H; Kuwae T; Sunaga K; Katsube N; Ishitani R
Life Sci; 2004 May; 74(26):3245-58. PubMed ID: 15094325
[TBL] [Abstract][Full Text] [Related]
50. Histone deacetylase inhibitor 4-phenylbutyrate suppresses GAPDH mRNA expression in glioma cells.
Appelskog IB; Ammerpohl O; Svechnikova IG; Lui WO; Almqvist PM; Ekström TJ
Int J Oncol; 2004 Jun; 24(6):1419-25. PubMed ID: 15138583
[TBL] [Abstract][Full Text] [Related]
51. Valproic acid improves outcome after rodent spinal cord injury: potential roles of histone deacetylase inhibition.
Lv L; Sun Y; Han X; Xu CC; Tang YP; Dong Q
Brain Res; 2011 Jun; 1396():60-8. PubMed ID: 21439269
[TBL] [Abstract][Full Text] [Related]
52. Prevention of hypoxia-induced neuronal apoptosis through histone deacetylase inhibition.
Li Y; Yuan Z; Liu B; Sailhamer EA; Shults C; Velmahos GC; Demoya M; Alam HB
J Trauma; 2008 Apr; 64(4):863-70; discussion 870-1. PubMed ID: 18404049
[TBL] [Abstract][Full Text] [Related]
53. Induction of GRP78 by valproic acid is dependent upon histone deacetylase inhibition.
Shi Y; Gerritsma D; Bowes AJ; Capretta A; Werstuck GH
Bioorg Med Chem Lett; 2007 Aug; 17(16):4491-4. PubMed ID: 17566732
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of nuclear factor kappaB is associated with neuroprotective effects of glycyrrhizic acid on glutamate-induced excitotoxicity in primary neurons.
Cherng JM; Lin HJ; Hung MS; Lin YR; Chan MH; Lin JC
Eur J Pharmacol; 2006 Oct; 547(1-3):10-21. PubMed ID: 16952351
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of histone deacetylase activity on specific embryonic tissues as a new mechanism for teratogenicity.
Menegola E; Di Renzo F; Broccia ML; Prudenziati M; Minucci S; Massa V; Giavini E
Birth Defects Res B Dev Reprod Toxicol; 2005 Oct; 74(5):392-8. PubMed ID: 16193500
[TBL] [Abstract][Full Text] [Related]
56. Valproic acid induces functional heat-shock protein 70 via Class I histone deacetylase inhibition in cortical neurons: a potential role of Sp1 acetylation.
Marinova Z; Ren M; Wendland JR; Leng Y; Liang MH; Yasuda S; Leeds P; Chuang DM
J Neurochem; 2009 Nov; 111(4):976-87. PubMed ID: 19765194
[TBL] [Abstract][Full Text] [Related]
57. Valproic acid, a mood stabilizer and anticonvulsant, protects rat cerebral cortical neurons from spontaneous cell death: a role of histone deacetylase inhibition.
Jeong MR; Hashimoto R; Senatorov VV; Fujimaki K; Ren M; Lee MS; Chuang DM
FEBS Lett; 2003 May; 542(1-3):74-8. PubMed ID: 12729901
[TBL] [Abstract][Full Text] [Related]
58. Characterization of valproic acid-initiated homologous recombination.
Sha K; Winn LM
Birth Defects Res B Dev Reprod Toxicol; 2010 Apr; 89(2):124-32. PubMed ID: 20437471
[TBL] [Abstract][Full Text] [Related]
59. Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicity.
Chen PS; Wang CC; Bortner CD; Peng GS; Wu X; Pang H; Lu RB; Gean PW; Chuang DM; Hong JS
Neuroscience; 2007 Oct; 149(1):203-12. PubMed ID: 17850978
[TBL] [Abstract][Full Text] [Related]
60. Reversible nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase upon serum depletion.
Schmitz HD
Eur J Cell Biol; 2001 Jun; 80(6):419-27. PubMed ID: 11484933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
